As expected, CD47 expression was significantly higher in NHL patients than in healthy controls, and in NHL samples, CD47 expression was also higher in CD19+ tumor cells than in non-tumor cells (Fig. 2B-C), which were further confirmed by western blotting analysis and qPCR assay (Fig. 2D-F). The gene discussed is CD19; the disease is neoplasm.